Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-31 @ 2:19 PM
Study NCT ID:
NCT02225093
Status:
COMPLETED
Last Update Posted:
2017-06-27
First Post:
2014-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer
Sponsor:
Astellas Pharma Europe B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-22
First Submit QC Date:
None
Study First Post Date:
2014-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-26
Last Update Post Date:
2017-06-27
Last Update Post Date Type:
ACTUAL